PDF Publication Title:
Text from PDF Page: 010
Mar. Drugs 2020, 18, 217 10 of 11 24. Corsetto, P.; Colombo, I.; Kopecka, J.; Rizzo, A.; Riganti, C. ω-3 Long Chain Polyunsaturated Fatty Acids as Sensitizing Agents and Multidrug Resistance Revertants in Cancer Therapy. IJMS 2017, 18, 2770. [CrossRef] [PubMed] 25. Allam-Ndoul, B.; Guénard, F.; Barbier, O.; Vohl, M.-C. A Study of the Differential Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Gene Expression Profiles of Stimulated Thp-1 Macrophages. Nutrients 2017, 9, 424. [CrossRef] 26. Li, J.; Elkhoury, K.; Barbieux, C.; Linder, M.; Grandemange, S.; Tamayol, A.; Francius, G.; Arab-Tehrany, E. Effects of Bioactive Marine-Derived Liposomes on Two Human Breast Cancer Cell Lines. Mar. Drugs 2020, 18, 211. [CrossRef] 27. Sun, Y.; Jia, X.; Hou, L.; Liu, X.; Gao, Q. Involvement of apoptotic pathways in docosahexaenoic acid-induced benefit in prostate cancer: Pathway-focused gene expression analysis using RT2 Profile PCR Array System. Lipids Health Dis. 2017, 16, 59. [CrossRef] 28. Guo, Y.; Zhu, S.; Wu, Y.; He, Z.; Chen, Y. Omega-3 free fatty acids attenuate insulin-promoted breast cancer cell proliferation. Nutr. Res. 2017, 42, 43–50. [CrossRef] 29. Bianchini, F.; Giannoni, E.; Serni, S.; Chiarugi, P.; Calorini, L. 22: 6 n -3 DHA inhibits differentiation of prostate fibroblasts into myofibroblasts and tumorigenesis. Br. J. Nutr. 2012, 108, 2129–2137. [CrossRef] 30. Kotze, A.F.; Luessen, H.L.; Thanou, M.; Verhoef, J.C.; de Boer, A.B.G.; Junginger, H.E.; Lehr, C.-M. Chitosan and chitosan derivatives as absorption enhancers for peptide drugs across mucosal epithelia. In Bioadhesive Drug Delivery Systems Fundamentals, Novel Approaches, and Development; Mathiowitz, E., Chickering, D.E., III, Lehr, C.-M., Eds.; Marcel Dekker: New York, NY, USA, 1999; pp. 341–386. 31. Rengel, R.G.; Barisic, K.; Pavelic, Z.; Grubisic, T.Z.; Cepelak, I.; Filipovic-Grcic, J. High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes. Eur. J. Pharm. Sci. 2002, 15, 441–448. [CrossRef] 32. Mazzarino, L.; Loch-Neckel, G.; Bubniak, L.D.S.; Mazzucco, S.; Santos-Silva, M.C.; Borsali, R.; Lemos-Senna, E. Curcumin-Loaded Chitosan-Coated Nanoparticles as a New Approach for the Local Treatment of Oral Cavity Cancer. J. Nanosci. Nanotechnol. 2015, 15, 781–791. [CrossRef] 33. Luo, Y.; Teng, Z.; Li, Y.; Wang, Q. Solid lipid nanoparticles for oral drug delivery: Chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. Carbohydr. Polym. 2015, 122, 221–229. [CrossRef] 34. Chirio, D.; Peira, E.; Sapino, S.; Dianzani, C.; Barge, A.; Muntoni, E.; Morel, S.; Gallarate, M. Stearoyl-Chitosan Coated Nanoparticles Obtained by Microemulsion Cold Dilution Technique. IJMS 2018, 19, 3833. [CrossRef] 35. Hasan, M.; Ben Messaoud, G.; Michaux, F.; Tamayol, A.; Kahn, C.J.F.; Belhaj, N.; Linder, M.; Arab-Tehrany, E. Chitosan-coated liposomes encapsulating curcumin: Study of lipid–polysaccharide interactions and nanovesicle behavior. RSC Adv. 2016, 6, 45290–45304. [CrossRef] 36. Hasan, M.; Elkhoury, K.; Kahn, C.J.F.; Arab-Tehrany, E.; Linder, M. Preparation, Characterization, and Release Kinetics of Chitosan-Coated Nanoliposomes Encapsulating Curcumin in Simulated Environments. Molecules 2019, 24, 2023. [CrossRef] 37. Takeuchi, H.; Yamamoto, H.; Niwa, T.; Hino, T.; Kawashima, Y. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm. Res. 1996, 13, 896–901. [CrossRef] 38. Wydro, P.; Krajewska, B.; Hac-Wydro, K. Chitosan as a lipid binder: A Langmuir monolayer study of chitosan—Lipid interactions. Biomacromolecules 2007, 8, 2611–2617. [CrossRef] 39. Mazzarino, L.; Travelet, C.; Ortega-Murillo, S.; Otsuka, I.; Pignot-Paintrand, I.; Lemos-Senna, E.; Borsali, R. Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications. J. Colloid Interface Sci. 2012, 370, 58–66. [CrossRef] 40. Leekumjorn, S.; Cho, H.J.; Wu, Y.; Wright, N.T.; Sum, A.K.; Chan, C. The role of fatty acid unsaturation in minimizing biophysical changes on the structure and local effects of bilayer membranes. Biochim. Biophys. Acta Biomembr. 2009, 1788, 1508–1516. [CrossRef] 41. Shi, X.-Y.; Sun, C.-M.; Wu, S.-K. Evaluation of in vitro stability of small unilamellar vesicles coated with collagen and chitosan. Polym. Int. 1999, 48, 212–216. [CrossRef] 42. Shi, M.; Cai, Q.; Yao, L.; Mao, Y.; Ming, Y.; Ouyang, G. Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol. Int. 2006, 30, 221–226. [CrossRef] 43. Das, K.C.; Das, C.K. Curcumin (diferuloylmethane), a singlet oxygen (O-1(2)) quencher. Biochem. Biophys. Res. Commun. 2002, 295, 62–66. [CrossRef]PDF Image | Growth-Inhibitory Effect of Chitosan-Coated Liposomes Encapsulating Curcumin
PDF Search Title:
Growth-Inhibitory Effect of Chitosan-Coated Liposomes Encapsulating CurcuminOriginal File Name Searched:
836c1ae26776a79725d4c4adee6113bbdd36.pdfDIY PDF Search: Google It | Yahoo | Bing
CO2 Organic Rankine Cycle Experimenter Platform The supercritical CO2 phase change system is both a heat pump and organic rankine cycle which can be used for those purposes and as a supercritical extractor for advanced subcritical and supercritical extraction technology. Uses include producing nanoparticles, precious metal CO2 extraction, lithium battery recycling, and other applications... More Info
Heat Pumps CO2 ORC Heat Pump System Platform More Info
| CONTACT TEL: 608-238-6001 Email: greg@infinityturbine.com | RSS | AMP |